🇺🇸 FDA

Company profile · Sponsor

Substipharm

EBDA4A8 · EMA pharma EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

Substipharm (EBDA4A8) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EBDA4A8
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (1)

Search pipeline →

  1. A randomized, investigator masked pilot study to establish the experimental conditions and select the criteria to compare topical application of 2 methyl aminolevulinate creams: evaluation of protoporphyrin IX formation in the skin of healthy subjects.

    Substipharm

    None - Healthy subjects

    phase 1 other active

    1 trial

Frequently asked questions

What is Substipharm?

Substipharm (EBDA4A8) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Substipharm sponsor?

We track 1 ClinicalTrials.gov-linked program for Substipharm, including A randomized, investigator masked pilot study to establish the experimental conditions and select the criteria to compare topical application of 2 methyl aminolevulinate creams: evaluation of protoporphyrin IX formation in the skin of healthy subjects.. Open each program for phase, modality, NCT IDs, and indication details.

Where does Substipharm company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.